Rakovina Therapeutics Stock Buy Hold or Sell Recommendation
| RKV Stock | CAD 0.08 0.01 23.08% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Rakovina Therapeutics is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Rakovina Therapeutics given historical horizon and risk tolerance towards Rakovina Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Rakovina Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Rakovina Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Rakovina and provide practical buy, sell, or hold advice based on investors' constraints. Rakovina Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Rakovina |
Execute Rakovina Therapeutics Buy or Sell Advice
The Rakovina recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Rakovina Therapeutics. Macroaxis does not own or have any residual interests in Rakovina Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Rakovina Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Rakovina Therapeutics Trading Alerts and Improvement Suggestions
| Rakovina Therapeutics had very high historical volatility over the last 90 days | |
| Rakovina Therapeutics has some characteristics of a very speculative penny stock | |
| Rakovina Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (2.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rakovina Therapeutics has accumulated about 4.37 M in cash with (1.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
| Roughly 32.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Rakovina Therapeutics Showcases AI in Cancer Therapy - TipRanks |
Rakovina Therapeutics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Rakovina analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Rakovina analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Rakovina Therapeutics Returns Distribution Density
The distribution of Rakovina Therapeutics' historical returns is an attempt to chart the uncertainty of Rakovina Therapeutics' future price movements. The chart of the probability distribution of Rakovina Therapeutics daily returns describes the distribution of returns around its average expected value. We use Rakovina Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Rakovina Therapeutics returns is essential to provide solid investment advice for Rakovina Therapeutics.
| Mean Return | 0.09 | Value At Risk | -9.09 | Potential Upside | 12.50 | Standard Deviation | 7.45 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Rakovina Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Rakovina Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Rakovina Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Rakovina Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Rakovina stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.15 | |
β | Beta against Dow Jones | -0.54 | |
σ | Overall volatility | 7.63 | |
Ir | Information ratio | -0.0041 |
Rakovina Therapeutics Volatility Alert
Rakovina Therapeutics is showing large volatility of returns over the selected time horizon. Rakovina Therapeutics is a penny stock. Although Rakovina Therapeutics may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Rakovina Therapeutics. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Rakovina instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Rakovina Therapeutics Fundamentals Vs Peers
Comparing Rakovina Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Rakovina Therapeutics' direct or indirect competition across all of the common fundamentals between Rakovina Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Rakovina Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Rakovina Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Rakovina Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Rakovina Therapeutics to competition |
| Fundamentals | Rakovina Therapeutics | Peer Average |
| Return On Equity | -0.67 | -0.31 |
| Return On Asset | -0.27 | -0.14 |
| Current Valuation | 7.21 M | 16.62 B |
| Shares Outstanding | 90.29 M | 571.82 M |
| Shares Owned By Insiders | 31.94 % | 10.09 % |
| Number Of Shares Shorted | 904 | 4.71 M |
| Price To Book | 1.90 X | 9.51 X |
| EBITDA | (2.16 M) | 3.9 B |
| Net Income | (2.61 M) | 570.98 M |
| Cash And Equivalents | 4.37 M | 2.7 B |
| Cash Per Share | 0.06 X | 5.01 X |
| Total Debt | 1.49 M | 5.32 B |
| Book Value Per Share | 0.04 X | 1.93 K |
| Cash Flow From Operations | (1.86 M) | 971.22 M |
| Short Ratio | 0.01 X | 4.00 X |
| Earnings Per Share | (0.04) X | 3.12 X |
| Beta | 0.046 | -0.15 |
| Market Capitalization | 7.22 M | 19.03 B |
| Total Asset | 5.15 M | 29.47 B |
| Retained Earnings | (10.93 M) | 9.33 B |
| Working Capital | 477.88 K | 1.48 B |
| Net Asset | 5.15 M |
Rakovina Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Rakovina . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 632511.0 | |||
| Daily Balance Of Power | 0.2308 | |||
| Rate Of Daily Change | 1.23 | |||
| Day Median Price | 0.0975 | |||
| Day Typical Price | 0.0917 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | 0.015 |
About Rakovina Therapeutics Buy or Sell Advice
When is the right time to buy or sell Rakovina Therapeutics? Buying financial instruments such as Rakovina Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Rakovina Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Communication Thematic Idea Now
Communication
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Communication theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Rakovina Stock Analysis
When running Rakovina Therapeutics' price analysis, check to measure Rakovina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rakovina Therapeutics is operating at the current time. Most of Rakovina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rakovina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rakovina Therapeutics' price. Additionally, you may evaluate how the addition of Rakovina Therapeutics to your portfolios can decrease your overall portfolio volatility.